Muzic JG, Schmitt AR, Wright AC, et al. Incidence and trends of basal cell carcinoma and cutaneous squamous cell carcinoma: a population-based study in Olmsted County, Minnesota, 2000 to 2010.

Patients who have cutaneous squamous-cell carcinoma with high-risk features are at risk for recurrence after definitive local therapy. The benefit of systemic adjuvant therapy options has not been ...

A phase II trial of perioperative oral itraconazole for the management of low risk basal cell carcinoma.. If you have the appropriate software installed, you can download article citation data to the ...

Neoadjuvant cemiplimab in cutaneous basal cell carcinoma of the head and neck.. If you have the appropriate software installed, you can download article citation data to the citation manager of your ...

Methods: Twenty dermatopathologically proven basal cell carcinoma lesions were treated with intralesional IFNa-2a injections three times weekly for 3 weeks.

Background: Basal cell carcinoma (BCC) is the most common skin cancer, exhibiting local invasiveness despite its low metastatic potential. Dermoscopy and histopathology are essential for diagnosis, ...

Urothelial carcinoma, or transitional cell carcinoma, is the most common bladder cancer and grows in the urothelial cells lining the urinary tract.

Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma The Institutional Review Board Has Approved the Increase in Number of Patients ...

A proof-of-concept study for precise mapping of pigmented basal cell carcinoma in asian skin using multispectral optoacoustic tomography imaging with level set segmentation.

Medicus Pharma Ltd Announces Positively Trending Interim Analysis for SKNJCT-003 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC) ...